Citizens Financial Group Inc Vertex Pharmaceuticals Inc Transaction History

Citizens Financial Group Inc

  • $2.97 Billion
  • Q1 2024

A detailed history of Citizens Financial Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Citizens Financial Group Inc holds 29,374 shares of VRTX stock, worth $14.3 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
29,374
Previous 29,796 1.42%
Holding current value
$14.3 Million
Previous $12.5 Million 1.42%
% of portfolio
0.41%
Previous 0.42%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 17, 2024
SELL
$407.69 - $446.08 $172,045 - $188,245
-422 Reduced 1.42%
29,374 $12.3 Million
Q4 2023

Feb 02, 2024
SELL
$343.0 - $410.68 $110,789 - $132,649
-323 Reduced 1.07%
29,796 $12.1 Million
Q3 2023

Nov 13, 2023
SELL
$338.18 - $362.46 $508,284 - $544,777
-1,503 Reduced 4.75%
30,119 $10.5 Million
Q2 2023

Aug 04, 2023
SELL
$314.42 - $351.91 $3.63 Million - $4.07 Million
-11,557 Reduced 26.77%
31,622 $11.1 Million
Q1 2023

May 10, 2023
SELL
$283.23 - $323.1 $212,705 - $242,648
-751 Reduced 1.71%
43,179 $13.6 Million
Q4 2022

Feb 09, 2023
SELL
$285.76 - $321.48 $505,795 - $569,019
-1,770 Reduced 3.87%
43,930 $12.7 Million
Q3 2022

Nov 10, 2022
BUY
$273.83 - $305.53 $60,790 - $67,827
222 Added 0.49%
45,700 $13.2 Million
Q2 2022

Aug 05, 2022
SELL
$234.96 - $292.55 $566,488 - $705,338
-2,411 Reduced 5.03%
45,478 $12.8 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $86,132 - $101,517
389 Added 0.82%
47,889 $12.5 Million
Q4 2021

Feb 10, 2022
BUY
$177.01 - $223.45 $7.61 Million - $9.61 Million
42,987 Added 952.51%
47,500 $10.4 Million
Q3 2021

Nov 05, 2021
BUY
$181.39 - $202.99 $818,613 - $916,093
4,513 New
4,513 $819,000
Q3 2020

Nov 12, 2020
SELL
$255.65 - $303.1 $144,442 - $171,251
-565 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$225.48 - $295.8 $9,470 - $12,423
-42 Reduced 6.92%
565 $164,000
Q1 2020

May 08, 2020
SELL
$199.77 - $247.81 $11,586 - $14,372
-58 Reduced 8.72%
607 $144,000
Q4 2019

Feb 07, 2020
BUY
$166.71 - $223.91 $64,850 - $87,100
389 Added 140.94%
665 $146,000
Q3 2019

Nov 01, 2019
BUY
$166.23 - $187.09 $29,921 - $33,676
180 Added 187.5%
276 $47,000
Q2 2019

Aug 09, 2019
BUY
$164.61 - $190.37 $6,584 - $7,614
40 Added 71.43%
96 $17,000
Q1 2019

May 09, 2019
SELL
$163.73 - $194.7 $4,093 - $4,867
-25 Reduced 30.86%
56 $10,000
Q1 2018

May 11, 2018
BUY
$151.6 - $177.13 $12,279 - $14,347
81 New
81 $13,000

Others Institutions Holding VRTX

# of Institutions
1,625
Shares Held
222M
Call Options Held
1.35M
Put Options Held
1.49M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $125B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Citizens Financial Group Inc Portfolio

Follow Citizens Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email